Search research articles
Contact Us
Filters
Showing results (161-170 of 237) with videos related to
Page
of 24
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 6, 2008
Vaccination of prostate cancer patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax): a phase 2 trial
Robert J Amato, Noel Drury, Stuart Naylor, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 10, 2019
HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets
Alison E Brown, Rosalie Hayes, Teymur Noori, et al.
Urology
|
July 1, 1991
Serum biomarkers in metastatic renal cell carcinoma
F H Dexeus, C J Logothetis, A Sella, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 3, 2009
The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors
Allan Lipton, Robert Uzzo, Robert J Amato, et al.
Emerging Infectious Diseases
|
February 20, 2015
Risk factors for death from invasive pneumococcal disease, Europe, 2010
Adoración Navarro-Torné, Joana Gomes Dias, Frantiska Hruba, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 1, 1985
Modified Blalock-Taussig shunt in infants and young children. Clinical and catheterization assessment
P P Karpawich, C P Bush, J R Antillon, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 1, 1990
Neonatal aortic stenosis
K Turley, E L Bove, J J Amato, et al.
Urology
|
February 25, 2000
Magnetic resonance imaging and magnetic resonance angiography before postchemotherapy retroperitoneal lymph node dissection
D A Corral, D G Varma, E F Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Vaccination of renal cell cancer patients with modified vaccinia ankara delivering tumor antigen 5T4 (TroVax) administered with interleukin 2: a phase II trial
Robert J Amato, William Shingler, Stuart Naylor, et al.
Vaccines
|
February 26, 2022
Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for Vaccines
Mepur H Ravindranath, Narendranath M Ravindranath, Senthamil R Selvan, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 237) with videos related to
Sort By:
Page
of 24
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 6, 2008
Vaccination of prostate cancer patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax): a phase 2 trial
Robert J Amato, Noel Drury, Stuart Naylor, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 10, 2019
HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets
Alison E Brown, Rosalie Hayes, Teymur Noori, et al.
Urology
|
July 1, 1991
Serum biomarkers in metastatic renal cell carcinoma
F H Dexeus, C J Logothetis, A Sella, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 3, 2009
The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors
Allan Lipton, Robert Uzzo, Robert J Amato, et al.
Emerging Infectious Diseases
|
February 20, 2015
Risk factors for death from invasive pneumococcal disease, Europe, 2010
Adoración Navarro-Torné, Joana Gomes Dias, Frantiska Hruba, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
February 1, 1985
Modified Blalock-Taussig shunt in infants and young children. Clinical and catheterization assessment
P P Karpawich, C P Bush, J R Antillon, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 1, 1990
Neonatal aortic stenosis
K Turley, E L Bove, J J Amato, et al.
Urology
|
February 25, 2000
Magnetic resonance imaging and magnetic resonance angiography before postchemotherapy retroperitoneal lymph node dissection
D A Corral, D G Varma, E F Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Vaccination of renal cell cancer patients with modified vaccinia ankara delivering tumor antigen 5T4 (TroVax) administered with interleukin 2: a phase II trial
Robert J Amato, William Shingler, Stuart Naylor, et al.
Vaccines
|
February 26, 2022
Four Faces of Cell-Surface HLA Class-I: Their Antigenic and Immunogenic Divergence Generating Novel Targets for Vaccines
Mepur H Ravindranath, Narendranath M Ravindranath, Senthamil R Selvan, et al.
Page
of 24